These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26862755)

  • 1. Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.
    Johnson DT; Hooker E; Luong R; Yu EJ; He Y; Gonzalgo ML; Sun Z
    PLoS One; 2016; 11(2):e0148851. PubMed ID: 26862755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
    Hsu JW; Hsu I; Xu D; Miyamoto H; Liang L; Wu XR; Shyr CR; Chang C
    Am J Pathol; 2013 May; 182(5):1811-20. PubMed ID: 23499463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation.
    Hsieh TF; Chen CC; Ma WL; Chuang WM; Hung XF; Tsai YR; Lin MH; Zhang Q; Zhang C; Chang C; Shyr CR
    Oncol Rep; 2013 Dec; 30(6):2917-22. PubMed ID: 24126741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate.
    Zhu C; Luong R; Zhuo M; Johnson DT; McKenney JK; Cunha GR; Sun Z
    J Biol Chem; 2011 Sep; 286(38):33478-88. PubMed ID: 21795710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
    Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
    Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex Bias.
    Shi MJ; Fontugne J; Moreno-Vega A; Meng XY; Groeneveld C; Dufour F; Kamoun A; Viborg Lindskrog S; Cabel L; Krucker C; Rapinat A; Dunois-Larde C; Lepage ML; Chapeaublanc E; Levrel O; Dixon V; Lebret T; Almeida A; De Reynies A; Rochel N; Dyrskjøt L; Allory Y; Radvanyi F; Bernard-Pierrot I
    Eur Urol; 2023 Jan; 83(1):70-81. PubMed ID: 36273937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latrophilin-3 as a downstream effector of the androgen receptor induces urothelial tumorigenesis.
    Goto T; Yasui M; Teramoto Y; Nagata Y; Mizushima T; Miyamoto H
    Mol Carcinog; 2024 Oct; 63(10):1847-1854. PubMed ID: 38925569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
    Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
    Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of bladder cancer development and progression by androgen receptor signals.
    Miyamoto H; Yang Z; Chen YT; Ishiguro H; Uemura H; Kubota Y; Nagashima Y; Chang YJ; Hu YC; Tsai MY; Yeh S; Messing EM; Chang C
    J Natl Cancer Inst; 2007 Apr; 99(7):558-68. PubMed ID: 17406000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancer.
    Zhang Z; Xu Q; Huang X; Yang J; Xu Y; Zhang G
    Int J Clin Exp Pathol; 2015; 8(9):10283-93. PubMed ID: 26617736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice.
    Ogawa K; St John M; Luiza de Oliveira M; Arnold L; Shirai T; Sun TT; Cohen SM
    Toxicol Pathol; 1999; 27(6):645-51. PubMed ID: 10588545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder.
    Luna-Velez MV; Dijkstra JJ; Heuschkel MA; Smit FP; van de Zande G; Smeets D; Sedelaar JPM; Vermeulen M; Verhaegh GW; Schalken JA
    Mol Oncol; 2021 Jul; 15(7):1882-1900. PubMed ID: 33797847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated.
    Overdevest JB; Knubel KH; Duex JE; Thomas S; Nitz MD; Harding MA; Smith SC; Frierson HF; Conaway M; Theodorescu D
    Proc Natl Acad Sci U S A; 2012 Dec; 109(51):E3588-96. PubMed ID: 23012401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
    Boorjian SA; Heemers HV; Frank I; Farmer SA; Schmidt LJ; Sebo TJ; Tindall DJ
    Endocr Relat Cancer; 2009 Mar; 16(1):123-37. PubMed ID: 18845648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
    Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
    Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S; Min W; Lee CC; Salim EI; Wanibuchi H; Sukata T; Fukushima S
    Cancer Lett; 1999 Jan; 135(2):137-44. PubMed ID: 10096421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
    Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of AR, 5αR1 and 5αR2 in bladder urothelial carcinoma and relationship to clinicopathological factors.
    Hata S; Ise K; Azmahani A; Konosu-Fukaya S; McNamara KM; Fujishima F; Shimada K; Mitsuzuka K; Arai Y; Sasano H; Nakamura Y
    Life Sci; 2017 Dec; 190():15-20. PubMed ID: 28947209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.